Calumet Specialty Products Stock EBITDA
| CLMT Stock | USD 21.40 0.43 1.97% |
Calumet Specialty Products fundamentals help investors to digest information that contributes to Calumet Specialty's financial success or failures. It also enables traders to predict the movement of Calumet Stock. The fundamental analysis module provides a way to measure Calumet Specialty's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Calumet Specialty stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | 418.2 M | 439.1 M |
Calumet | EBITDA |
Calumet Specialty Products Company EBITDA Analysis
Calumet Specialty's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Calumet Specialty EBITDA | 418.2 M |
Most of Calumet Specialty's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Calumet Specialty Products is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Calumet EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Calumet Specialty is extremely important. It helps to project a fair market value of Calumet Stock properly, considering its historical fundamentals such as EBITDA. Since Calumet Specialty's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Calumet Specialty's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Calumet Specialty's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Calumet Ebitda
Ebitda |
|
According to the company disclosure, Calumet Specialty Products reported earnings before interest,tax, depreciation and amortization of 418.2 M. This is 93.02% lower than that of the Oil, Gas & Consumable Fuels sector and 75.0% lower than that of the Energy industry. The ebitda for all United States stocks is 89.27% higher than that of the company.
Calumet EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Calumet Specialty's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Calumet Specialty could also be used in its relative valuation, which is a method of valuing Calumet Specialty by comparing valuation metrics of similar companies.Calumet Specialty is currently under evaluation in ebitda category among its peers.
Calumet Specialty Current Valuation Drivers
We derive many important indicators used in calculating different scores of Calumet Specialty from analyzing Calumet Specialty's financial statements. These drivers represent accounts that assess Calumet Specialty's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Calumet Specialty's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 285.5M | 245.3M | 1.0B | 1.3B | 1.4B | 1.1B | |
| Enterprise Value | 1.6B | 1.5B | 2.6B | 3.0B | 3.6B | 1.9B |
Calumet Specialty ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Calumet Specialty's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Calumet Specialty's managers, analysts, and investors.Environmental | Governance | Social |
Calumet Specialty Institutional Holders
Institutional Holdings refers to the ownership stake in Calumet Specialty that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Calumet Specialty's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Calumet Specialty's value.| Shares | Bienville Capital Management, Llc | 2024-09-30 | 341.1 K | Royal Bank Of Canada | 2024-09-30 | 318.2 K | Two Seas Capital Lp | 2024-09-30 | 310 K | Barnett & Co Inc | 2024-09-30 | 279.3 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 251.8 K | State Street Corp | 2024-09-30 | 243.3 K | Lpl Financial Corp | 2024-09-30 | 195.5 K | Ubs Group Ag | 2024-09-30 | 187.2 K | Brown Advisory Holdings Inc | 2024-09-30 | 185.6 K | Wasserstein Debt Opportunities Management Lp | 2024-09-30 | 6.9 M | Adams Asset Advisors Llc | 2024-09-30 | 5.3 M |
Calumet Fundamentals
| Return On Equity | -11.72 | ||||
| Return On Asset | 0.0167 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | (0.04) % | ||||
| Current Valuation | 3.94 B | ||||
| Shares Outstanding | 85.9 M | ||||
| Shares Owned By Insiders | 21.24 % | ||||
| Shares Owned By Institutions | 37.43 % | ||||
| Number Of Shares Shorted | 5.37 M | ||||
| Price To Earning | 286.67 X | ||||
| Price To Book | 19.32 X | ||||
| Price To Sales | 0.45 X | ||||
| Revenue | 4.18 B | ||||
| Gross Profit | 370.2 M | ||||
| EBITDA | 418.2 M | ||||
| Net Income | 47.1 M | ||||
| Cash And Equivalents | 50.5 M | ||||
| Cash Per Share | 0.64 X | ||||
| Total Debt | 2.19 B | ||||
| Current Ratio | 0.60 X | ||||
| Book Value Per Share | (7.83) X | ||||
| Cash Flow From Operations | (14.9 M) | ||||
| Short Ratio | 7.59 X | ||||
| Earnings Per Share | (2.82) X | ||||
| Price To Earnings To Growth | 2.71 X | ||||
| Target Price | 24.6 | ||||
| Number Of Employees | 1.58 K | ||||
| Beta | 1.91 | ||||
| Market Capitalization | 1.91 B | ||||
| Total Asset | 2.75 B | ||||
| Retained Earnings | (421.9 M) | ||||
| Working Capital | (318 M) | ||||
| Current Asset | 609 M | ||||
| Current Liabilities | 626.6 M | ||||
| Net Asset | 2.75 B |
About Calumet Specialty Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Calumet Specialty Products's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Calumet Specialty using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Calumet Specialty Products based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Calumet Stock Analysis
When running Calumet Specialty's price analysis, check to measure Calumet Specialty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calumet Specialty is operating at the current time. Most of Calumet Specialty's value examination focuses on studying past and present price action to predict the probability of Calumet Specialty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calumet Specialty's price. Additionally, you may evaluate how the addition of Calumet Specialty to your portfolios can decrease your overall portfolio volatility.